<?xml version="1.0" encoding="UTF-8"?>
<p>Consistently, a retrospective, multicenter study including 191 patients with COVID-19 illustrated that elevated hs-cTnI levels were evidenced in 17% of the whole cohort and those myocardial injuries mainly occurred in nonsurvivors (59% vs. 1%, 
 <italic>p</italic> &lt; 0.0001) [
 <xref rid="B7-jcm-09-01407" ref-type="bibr">7</xref>]. A meta-analysis of six studies with 1527 COVID-19 patients found that at least 8% of the patients suffered from acute myocardial injury and the risk of myocardial injury was 13-fold higher in severe patients than nonsevere patients [
 <xref rid="B20-jcm-09-01407" ref-type="bibr">20</xref>].
</p>
